Inventor
KANGAWA KENJI
JP32 patents
⚠️ This page may combine multiple inventors who share the name “KANGAWA KENJI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SUNTORY LTD
9 patentsUS5354900AOct 11, 1994
An H-ANP peptide, pharmaceutical composition and method of use
SUNTORY LTD29 citations92
US5338830AAug 16, 1994
Biologically active peptide derived from chicken (chicken CNP)
SUNTORY LTD21 citations92
US5336759AAug 9, 1994
Biologically active peptide derived from frog (frog CNP)
SUNTORY LTD26 citations92
US4656158AApr 7, 1987
Peptide, and production and use thereof
SUNTORY LTD25 citations92
US6020168AFeb 1, 2000
Porcine CNP gene and precursor protein
SUNTORY LTD37 citations90
US5973134AOct 26, 1999
Rat CNP complementary DNA and precursor protein
SUNTORY LTD25 citations89
US4657891AApr 14, 1987
Diuretic peptide, and production and use thereof
SUNTORY LTD8 citations74
US5118615AJun 2, 1992
Peptide and gene coding for same
SUNTORY LTD7 citations72
US4748232AMay 31, 1988
Peptide production and use thereof
SUNTORY LTD2 citations63
KANGAWA KENJI
7 patentsUS7385026B1Jun 10, 2008
Modified ghrelin polypeptides
KANGAWA KENJI33 citations95
US8227570B2Jul 24, 2012
Modified gherlin peptides
KANGAWA KENJI4 citations72
US8524871B2Sep 3, 2013
Modified gherlin peptides
KANGAWA KENJI2 citations61
US10653637B2May 19, 2020
Preventives or remedies for hepatopathy
KANGAWA KENJI0 citations51
US9938332B2Apr 10, 2018
Modified ghrelin peptides
KANGAWA KENJI0 citations51
US9573986B2Feb 21, 2017
Modified ghrelin peptides
KANGAWA KENJI0 citations51
US9233143B2Jan 12, 2016
Medicinal agent for preventing exacerbation of malignant tumor, comprising combination of natriuretic peptide receptor GC-A and GC-B agonists
KANGAWA KENJI0 citations45
SHIONOGI & CO
6 patentsUS5639855AJun 17, 1997
Adrenomedullin
SHIONOGI & CO56 citations95
US5910416AJun 8, 1999
Adrenomedullin
SHIONOGI & CO24 citations92
US5830703ANov 3, 1998
DNA encoding adrenomedullin
SHIONOGI & CO21 citations92
US9486503B2Nov 8, 2016
Medicinal agent for suppressing malignant tumor metastasis
SHIONOGI & CO2 citations60
US9987333B2Jun 5, 2018
Method for suppressing malignant tumor metastasis
SHIONOGI & CO0 citations49
US7211380B1May 1, 2007
Physiologically active polypeptide and DNA
SHIONOGI & CO1 citations48
NAT CEREBRAL & CARDIOVASCULAR CT
3 patentsUS12186350B2Jan 7, 2025
Antitumor effect potentiator
NAT CEREBRAL & CARDIOVASCULAR CT0 citations57
US10071099B2Sep 11, 2018
Medicament for suppressing malignant tumor metastasis
NAT CEREBRAL & CARDIOVASCULAR CT0 citations49
US7943580B2May 17, 2011
Polypeptide and the use thereof
NAT CEREBRAL & CARDIOVASCULAR CT0 citations48